Skip to main content

Loading market ticker...

Lincoln Pharma

Healthcare NSE:LINCOLN

632.95INR
-125.20 ( -16.51%)

Last update at May 29, 2026, midnight

Day Range

620.00697.85
LowHigh

52 Week Range

464.40 825.33
LowHigh

Fundamentals

  • Previous Close 758.15
  • Market Cap 9687.10M
  • Volume545,069
  • P/E Ratio 12.10
  • EBITDA 1006.36M
  • Revenue TTM 6321.65M
  • Revenue Per Share TTM 315.61
  • Gross Profit TTM 3315.18M
  • Diluted EPS TTM 39.96

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 1091.89M 1222.43M 1004.80M 959.39M 837.21M
Net income 823.46M 933.05M 728.99M 693.55M 622.50M
Total Revenue 6232.30M 5805.50M 5049.55M 4681.97M 4147.48M
Gross Profit 3319.11M 2974.72M 2592.09M 2462.71M 2133.28M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 7970.06M 7002.90M 5874.20M 5343.57M 4593.72M
Intangible assets 4.40M 3.26M 2.95M 3.83M 3.98M
Other current assets 234.19M 116.67M 113.05M 159.60M 0.01M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 76.67M 6.95M -18.82M -45.04M -7.03M
Operating Cash 930.16M 632.17M 392.62M 761.32M 692.70M
Free Cash Flow 737.71M 237.41M 249.80M 306.07M 605.19M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
LINCOLN
Lincoln Pharma 		-125.20 -16.51% 632.95 9687.10 12.10
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-45.10 -2.45% 1799.20 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-130.50 -1.92% 6667.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-127.00 -2.80% 4410.80 1362716.66 63.48
CIPLA
Cipla Limited 		-17.20 -1.21% 1401.00 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.